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ell migration involves many steps, including membrane
protrusion and the development of new adhesions.
Here we have investigated whether there is a link
between actin polymerization and integrin engagement. In
response to signals that trigger membrane protrusion, the
actin-related protein (Arp)2/3 complex transiently binds to
vinculin, an integrin-associated protein. The interaction is
regulated, requiring phosphatidylinositol-4,5-bisphosphate
and Rac1 activation, and is sufﬁcient to recruit the Arp2/3
complex to new sites of integrin aggregation. Binding of
the Arp2/3 complex to vinculin is direct and does not
C
 
depend on the ability of vinculin to associate with actin.
We have mapped the binding site for the Arp2/3 complex
to the hinge region of vinculin, and a point mutation in this
region selectively blocks binding to the Arp2/3 complex.
Compared with WT vinculin, expression of this mutant in
vinculin-null cells results in diminished lamellipodial
protrusion and spreading on ﬁbronectin. The recruitment of
the Arp2/3 complex to vinculin may be one mechanism
through which actin polymerization and membrane pro-
trusion are coupled to integrin-mediated adhesion.
 
Introduction
 
Cell migration is a multistep process that involves protru-
sion, adhesion to the underlying substratum, contraction
and breaking of older adhesions at the cell rear (Heath and
Holifield, 1991; Condeelis, 1998; Kaverina et al., 2002). In
order to give rise to productive cell motility, these processes
must be coordinated, and perturbation of any of these events
has consequences on a cell’s ability to migrate. For example,
membrane extensions that adhere to the substratum during
the extension process, can develop into a dominant lamelli-
podium and give rise to forward cell movement. However, if
the membrane protrusions fail to adhere to the substratum,
the extension will fold back upon itself, forming a membrane
ruffle that will not support cell migration. Better under-
standing of how these processes are coordinated is essential
for understanding cell migration (Condeelis, 1998).
The ability to extend protrusions is driven by actin poly-
merization. Proteins that regulate the assembly and disas-
sembly of actin have been localized to the leading edge of
migrating cells (for review see Borisy and Svitkina, 2000;
Cooper and Schafer, 2000; Pollard et al., 2000; Condeelis,
2001). A key component regulating nucleation of polymer-
ization is the Arp2/3 complex, which is comprised of seven
subunits, actin-related protein (Arp)*2, Arp3, p41-Arc,
p34-Arc, p21-Arc, p20-Arc, and p16-Arc in mammalian
cells (Welch et al., 1997). The Arp2/3 complex becomes
activated downstream from Cdc42 and Rac1. GTPases that
induce filopodial and lamellipodial extension, respectively.
Rac1 activates the Arp2/3 complex via the Scar/WAVE
proteins (Machesky and Insall, 1998; Miki et al., 1998),
whereas Cdc42 binds and activates Wiskott-Aldrich Syndrome
protein 
 
(
 
WASP) or N-WASP via a conserved acidic domain
(Rohatgi et al., 1999). Activated WASP binds and induces a
conformational change in the Arp2/3 complex that permits
the Arp2 and Arp3 subunits of the complex to form the
template for the daughter filament (Robinson et al., 2001).
Nucleation of actin polymerization in this fashion triggers
the addition of actin monomers close to the membrane. In
addition, the Arp2/3 complex also binds to the sides of exist-
ing filaments (Svitkina and Borisy, 1999). This binding to
F-actin activates the Arp2/3 complex in a manner coopera-
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tive with the activation by the WASP/Scar family of proteins
(Higgs and Pollard, 2001). Nucleation of existing filaments
in this manner forms a highly branched, dendritic network
(Mullins et al., 1998; Svitkina and Borisy, 1999; Blanchoin
et al., 2000; Pantaloni et al., 2000; Bailly et al., 2001), and
this branching has been shown to be essential for lamellipo-
dial extension (Bailly et al., 2001). The continued addition
of actin monomers in this branched network is thought to
provide the driving force for the extension of membrane that
occurs during lamellipodial protrusion.
Another group of proteins localized and activated in ex-
tending lamellipodia are the integrins, cell surface receptors
that serve as transmembrane links between the extracellular
matrix on the outside and cytoskeleton on the inside of the
cell (Nishizaka et al., 2000; Kiosses et al., 2001). The integrins
bind a number of cytoskeletal proteins, including talin, 
 
 
 
-acti-
nin, and filamin, all of which bind F-actin (Hemler, 1998; for
review see Critchley, 2000; Liu et al., 2000; Zamir and Gei-
ger, 2001a,b). Additionally, both talin and 
 
 
 
-actinin bind
vinculin, another actin-binding protein (Jockusch and Isen-
berg, 1981; Johnson and Craig, 1995a). Together, these ob-
servations have led to the idea that multiple protein complexes
mediate attachment of integrins to actin filaments.
In order for cells to migrate effectively, it is important that
protrusive activity is linked to adhesion. Potential mecha-
nisms by which this may occur are via integrin engagement
activating Rac1 (Clark et al., 1998; Price et al., 1998; Del
Pozo et al., 2000) or recruiting activated Rac1 to these sites
(Del Pozo et al., 2002). The local activation of Rac1 at the
leading edge of cells (Kraynov et al., 2000) is thought to
stimulate the Arp2/3 complex in this region, thereby trigger-
ing actin polymerization and growth of the dendritic net-
work of actin filaments in the lamellipodium. It seemed to
us that besides this signaling pathway linking adhesion to ac-
tin polymerization, there may also exist a structural link be-
tween integrin engagement and actin polymerization, so that
newly engaged integrins might couple to the Arp2/3 com-
plex. Here, we have identified an interaction between vincu-
lin and the Arp2/3 complex that occurs transiently in re-
sponse to signals that trigger membrane protrusion. This
interaction is regulated by phosphatidylinositol-3-kinase
(PI3K) and Rac1 activity, and is sufficient to recruit the
Arp2/3 complex to new sites of integrin clustering.
 
Results
 
Transient binding of the Arp2/3 complex to vinculin
 
Migration of many vertebrate cells requires both actin poly-
merization and adhesion to the substratum. In this study
we examined whether there is a possible association of the
Arp2/3 complex with one of the proteins found at the cyto-
plasmic face of matrix adhesions (for review see Critchley,
2000). In preliminary work, we looked for possible coelu-
tion of Arp2/3 with talin, vinculin, or 
 
 
 
-actinin in column
fractions of platelet lysates. We observed coelution of the
Arp2/3 complex with vinculin and found Arp2/3 cosedi-
menting with vinculin immunoprecipitated from these frac-
tions (unpublished data).
To explore the interaction of vinculin with Arp2/3, we ex-
amined their coimmunoprecipitation from cultured fibro-
blasts. Only low levels of association were detected (unpub-
lished data). To examine whether the interaction might be
stimulated when cells are induced to extend membrane ruf-
fles and lamellipodia, we looked for coimmunoprecipitation
from A431 cells, which form large membrane ruffles when
stimulated with EGF (Brunk et al., 1976; Diakonova et al.,
1995). EGF induced a transient association of the Arp2/3
complex with vinculin. This peaked within 30 s and was di-
minished by 15–20 min, depending on the experiment (Fig.
1 A). The time at which the Arp2/3 complex was bound to
vinculin is similar to the time frame for induction of ruffles
by EGF in A431 cells (unpublished data). In addition, re-
cruitment of the Arp2/3 complex to vinculin did not corre-
late with actin binding, which was constant with it being in-
dependent of actin binding. This interaction was specific for
vinculin, because talin, another actin binding protein, was
unable to recruit the Arp2/3 complex in response to EGF
stimulation (Fig. 1 B). Membrane protrusion is also stimu-
lated by cell spreading on extracellular matrix (ECM). Using
Hs68 cells, we investigated the association of the Arp2/3
complex with vinculin that was immunoprecipitated from
stationary cells or from those spreading on a fibronectin (FN)
matrix. For this experiment, adhesion and spreading were ac-
Figure 1. Factors that trigger membrane protrusion induce the 
association of the Arp2/3 complex with vinculin. (A and B) Growth 
factor treatment of cells. Serum-starved A431 cells were stimulated 
with buffer (0) or human EGF (100 ng/ml) for the times indicated 
(min). The cells were lysed and vinculin or talin was immuno-
precipitated. 20% of resulting immunoprecipitates were subjected 
to Western blot analysis with antibodies against vinculin (A) or talin 
(B), 10% was used for the actin blots (A and B, bottom), and 70% 
was used for the blots of p34 subunit of the Arp2/3 complex 
(p34, bottom). LYS denotes a sample of whole cell lysate. (C) Cells 
spreading on FN. Hs68, human foreskin fibroblasts, were plated 
into each well of a FN-coated 6-well plate in serum-free DME. 
The cells were centrifuged onto the dish and allowed to recover 
at 37 C for the times indicated. The cells were lysed, vinculin was 
immunoprecipitated, and cells were blotted as described in A and 
B. ST, stationary cells that had been plated for 4 h on a similar 
concentration of FN. 
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celerated by centrifuging the cells onto FN-coated coverslips.
A low amount of the Arp2/3 complex was detected associat-
ing with vinculin in stationary cells, and this was greatly in-
creased as cells spread on FN (Fig. 1 C). Similar to the EGF-
treated cells, the interaction was transient and over by 15–20
min, at which time spreading was largely complete.
 
Binding of the Arp2/3 complex to vinculin 
is regulated by PI3K and Rac1
 
These results suggest that there is a signal that induces bind-
ing of the Arp2/3 complex to vinculin. One signaling path-
way activated downstream of both EGF stimulation and
integrin-mediated adhesion is the PI3K pathway (Van-
haesebroeck and Waterfield, 1999). To address whether
PI3K activity affects the interaction of the Arp2/3 complex
with vinculin, we explored the effects of PI3K inhibitors,
wortmannin and LY294002, on EGF-induced association
of these proteins. We found that 100 nM wortmannin
(Fig. 2 A) or 50 nM LY294002 (unpublished data)
blocked EGF-dependent recruitment of the Arp2/3 com-
plex to vinculin.
PI3K has been identified as an upstream activator of the
small GTP-binding protein Rac1 (Ma and Abrams, 1999),
and Rac1 becomes activated in response to growth factor
stimulation (Hawkins et al., 1995; Sander et al., 1999; Liu
and Burridge, 2000; Zondag et al., 2000) and integrin-
mediated adhesion (Price et al., 1998). Additionally, Rac1
stimulates actin polymerization via the Arp2/3 complex (for
review see Higgs and Pollard, 2001). We explored the role of
Rac1 activation in recruitment of the Arp2/3 complex to
vinculin. EGF induced an increase in Rac1 activity that per-
sisted for the first 10–15 min of EGF stimulation, coinci-
dent with the Arp2/3 complex binding to vinculin (Fig. 3
A). Expression of dominant negative Rac1 in A431 cells
abolished Rac1 activation by EGF and prevented binding of
the Arp2/3 complex to vinculin induced by EGF (Fig. 3 A).
Similarly, dominant negative Cdc42 impaired binding of
the Arp2/3 complex to vinculin, albeit to a lesser extent (un-
published data). The observation that Rac1 activates Scar/
WAVE, itself an activator of the Arp2/3 complex (Machesky
and Insall, 1998; Miki et al., 1998, 2000), is consistent with
the Arp2/3 complex needing to be activated to bind vincu-
lin. Expression of constitutively active Rac1 (L61Rac1) or
loading of cells with GST-L61Rac1 triggered association of
the Arp2/3 complex with vinculin (Fig. 3 B). These results
suggest that in response to stimuli that trigger membrane
protrusion, the Arp2/3 complex is recruited to vinculin in a
PI3K- and Rac1-dependent fashion.
PI3K and Rac1 trigger numerous downstream signaling
events. At least two of the events downstream of Rac, PIP
 
2
 
production and Scar/WAVE activation, potentially could
regulate the association of the Arp2/3 complex with vincu-
lin. PIP
 
2
 
 has been shown to induce a conformation change
Figure 2. PI3K is required for recruitment of the Arp2/3 complex 
to vinculin. Effect of inhibition of PI3K by wortmannin (A) on 
recruitment of the Arp2/3 complex to vinculin. Serum-starved A431 
cells were pretreated with DMSO or 100 nM wortmannin (WM) for 
30 min and then left resting (0) or stimulated with EGF for the times 
indicated (min). Vinculin was immunoprecipitated and blotted for 
vinculin or p34-Arc as described in Fig. 1.
Figure 3. Rac1 is necessary and sufficient for recruitment of the 
Arp2/3 complex to vinculin. (A) Effect of dominant negative Rac1 
on the recruitment of proteins to vinculin. A431 cells were transiently 
transfected with vector alone (MOCK) or myc-tagged N17Rac1 
(N17Rac1), allowed to recover for 12 h, and then serum starved 
for an additional 18–24 h in DME. Cells were stimulated with 100 
ng/ml of EGF as in Fig. 1 for the times given (min), and vinculin 
immunoprecipitated. (B) Effect of constitutively active Rac1 on the 
recruitment of proteins to vinculin. A431 cells were transiently 
transfected with AU-tagged L61Rac1 (L61), allowed to recover for 
12h, and then serum starved for an additional 18–24 h in DME. 
Vinculin immunoprecipitates were blotted for p34. The graphs 
beneath each panel indicate the levels of GTP-bound Rac1. Each 
number represents the mean fold activation   SEM in Rac1 activity 
over unstimulated cells from three independent experiments. 
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in vinculin that allows for increased association with binding
partners such as talin and VASP (Gilmore and Burridge,
1996; Weekes et al., 1996; Huttelmaier et al., 1998). Scar/
WAVE activation exposes its COOH-terminal VCA do-
main. In turn, this domain binds to the Arp2/3 complex,
thereby activating it (Miki et al., 1998; Machesky et al.,
1999). To address whether PIP
 
2
 
 production or Arp2/3 com-
plex activation is important for binding of the Arp2/3 com-
plex to vinculin, we immunoprecipitated vinculin from cell
lysates incubated in the presence or absence of exogenous
PIP
 
2
 
 or GST-VCA domain. We observed that binding of
the Arp2/3 complex to vinculin was stimulated slightly by
PIP
 
2
 
 and more by the VCA domain (Fig. 4). Only in the
presence of both PIP
 
2
 
 and GST-VCA was the recruitment of
the Arp2/3 complex to vinculin restored to the level seen in
an EGF-stimulated cell. An alternative hypothesis is that
these two pathways are needed to give rise to an accumula-
tion of F-actin that would then potentiate the interaction of
the Arp2/3 complex with vinculin. We examined the effect
of latrunculin treatment on the recruitment of the Arp2/3
complex to vinculin. We found that the latrunculin treat-
ment of cells disassembled stress fibers but had no effect on
Arp2/3 complex recruitment to vinculin (unpublished data).
Taken together, these results suggest that both activation of
the Arp2/3 complex and the conformational change in vin-
culin contribute to the interaction of these two proteins.
 
Recruitment of the Arp2/3 complex to early sites 
of integrin engagement
 
To explore whether vinculin provides a link between integrins
and the Arp2/3 complex, we investigated whether the Arp2/3
complex localizes to sites of integrin aggregation. For these ex-
periments, we used a GFP fusion protein of the p34-Arc sub-
unit of the Arp2/3 complex (p34GFP) and antibodies against
vinculin. In cells plated on a FN-coated surface, we did not
detect the Arp2/3 complex in focal adhesions revealed by
staining for vinculin (Fig. 5 A). However, p34GFP and vincu-
lin colocalized in structures that we interpret as focal com-
plexes at the leading edge (Fig. 5 A, arrows). Focal complexes
are the small adhesive structures induced by Rac or Cdc42 ac-
tivation, that develop at the cell periphery and that often ma-
ture into focal adhesions (Nobes and Hall, 1995). Microinjec-
tion of cells with 61LRac and the Rho inhibitor, C3, revealed
colocalization of Arp3 with vinculin in small structures at the
cell periphery (Fig. 5 B). These observations support the bio-
chemical data indicating that the association of the Arp2/3
complex with vinculin is transient and only seen in the most
recently formed sites of adhesion at the cell periphery.
The transient association of the Arp2/3 complex with sites
of integrin engagement was investigated further using FN-
coated beads applied to cells at different time points. Re-
cruitment of the Arp2/3 complex to beneath the beads was
visualized again using p34GFP. Early after depositing FN-
coated beads on cells, 74% of the beads recruited p34GFP
beneath the beads (Fig. 5 C). When GFP alone was ex-
pressed, this showed no significant accumulation beneath
FN-coated beads. Recruitment of p34GFP did not occur to
beads coated with polylysine and the effect was specific for
the 
 
 
 
1-integrins, as human leukocyte antigen (HLA) was
not recruited to the beads. We tested if the recruitment of
the Arp2/3 complex to 
 
 
 
1-integrins could potentially be
mediated by vinculin by examining if the recruitment was
transient or PI3K dependent. We found that recruitment of
p34GFP was decreased to background levels (
 
 
 
10%) at 35
min after adhesion of the beads to cells (Fig. 5 D). Treat-
ment of cells with 100 nM wortmannin prevented the re-
cruitment of the Arp2/3 complex to the FN-coated beads
(Fig. 5 D). Together, these results suggest that a transient as-
sociation of the Arp2/3 complex with vinculin recruits this
complex to new sites of integrin engagement, but not to re-
gions where integrins have been engaged for a long time
such as focal adhesions. Further evidence supporting this
idea comes from experiments using a vinculin mutant un-
able to bind the Arp2/3 complex (see below; see Fig. 10).
 
The Arp2/3 complex binds directly to vinculin amino 
acids 850–881
 
To explore the role of this interaction between the Arp2/3
complex and vinculin, we considered generating a mutant
form of vinculin that could not bind the Arp2/3 complex.
This would allow us to examine the phenotype of this vincu-
lin when expressed in vinculin-null cells. We mapped the
Arp2/3 binding site on vinculin using vinculin fragments ex-
pressed as GST fusion proteins (Fig. 6 A). Several overlap-
ping fragments bound to the Arp2/3 complex and identified
amino acids 850–881 as the critical domain (Fig. 6 B). Be-
cause these experiments were carried out using crude platelet
extracts, we determined whether the association of Arp2/3
complex depended on the ability of vinculin to recruit actin.
We examined whether the Arp2/3 complex was retrieved
from platelet extracts using a vinculin fusion protein con-
taining an intact actin binding site (Vin 881–1066), but
lacking an Arp2/3 binding site. The converse experiment
was also performed with a vinculin fusion protein contain-
Figure 4. PIP2 and GST-VCA induce binding of the Arp2/3 complex 
to vinculin. Serum-starved A431 cells were stimulated with buffer 
alone or with 100 ng/ml EGF for 5 min. The cells were lysed in 500 
 l vol as described in the text, and the lysates were incubated in the 
presence of no exogenous proteins or 30  g of GST, 10 mM PIP2, 
10 mM PIP2  30  g GST–VCA, or 30  g of GST–VCA for 20 min at 
4 C. Vinculin immunoprecipitates were prepared and analyzed as 
described above. In three independent experiments, compared with 
the level of Arp2/3 binding to vinculin in response to 5 min EGF 
stimulation (100%), the level of Arp2/3 complex recruitment in 
response to the various stimuli was 13%   7% (PIP2), 27%   15% 
(GST–VCA), and 94%   11% (PIP2   GST–VCA). 
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ing an intact Arp2/3 binding site (Vin 811–881), but lack-
ing intact actin binding site. Fusion proteins that bound ac-
tin were not able to recruit the Arp2/3 complex and vice
versa (Fig. 6 C). We conclude that actin binding to vinculin
is not required for binding of the Arp2/3 complex.
We next examined whether the association of the Arp2/3
complex to vinculin was direct using purified proteins. Two
GST fusion proteins containing vinculin residues 1–811 and
811–881 were incubated with pure Arp2/3 complex. These
experiments demonstrated direct binding between the Arp2/3
complex and residues 811–881 of vinculin (Fig. 7).
To define further which amino acids within this sequence of
vinculin were important for binding of the Arp2/3 complex,
we made a number of mutations in evolutionarily conserved
residues in this region. Two of these mutants, P876A and
P878A, were unable to bind the Arp2/3 complex but were able
to recruit ponsin, vinexin and VASP, other proteins that have
been shown to bind to this region of vinculin (Fig. 6 D).
To ensure that the mutation was capable of interferring with
binding of the Arp2/3 complex in the context of full length
vinculin, we subcloned the mutation into full length vinculin
and assessed its ability to recruit the Arp2/3 complex in vincu-
lin immunoprecipitates. In response to FBS stimulation, the
mutant was unable to recruit the Arp2/3 complex to wildtype
levels (Fig. 6 E). This impaired binding was not due to differ-
ences in the levels of expression as both the WT and mutant
vinculin were expressed at similar levels (unpublished data).
We next examined whether the mutant could carry out
functions normally ascribed to vinculin. We examined
whether the mutant vinculin was able to localize to and con-
centrate in focal adhesions when expressed in the vinculin-
null cells. We found a normal distribution of vinculin in focal
adhesions in cells reexpressing the WT or mutant vinculin
(Fig. 8). No vinculin staining was detected in the vinculin
null cells transfected with the vector alone.
 
Recruitment of the Arp2/3 complex to vinculin is 
important for some integrin-mediated events
 
Previous studies demonstrated that fibroblasts isolated from
embryos lacking vinculin have reduced adhesion, spreading
Figure 5. Recruitment of the Arp2/3 
complex to sites of integrin aggregation. 
(A) REF52 cells expressing GFP or p34GFP 
were plated on FN-coated coverslips for 
1.5 h at 37 C. (B) Serum-starved Swiss3T3 
cells were plated on FN-coated cover-
slips, and microinjected with 61LRac 
and C3. The cells were examined by 
immunofluorescence using antibodies 
against vinculin and the Arp3 subunit of 
the Arp2/3 complex. Sites of colocal-
ization of the Arp2/3 complex with 
vinculin (focal complexes) are indicated 
with arrows in A. Bar, 20  m. (C and D) 
Hela cells expressing GFP or p34GFP 
were plated on collagen and presented 
with beads coated with fibronectin (FN) 
or poly-lysine (PL beads) for 20 min 
(C and D marked early) or 35 min (D, late). Cells were stained for  1 integrins or HLA. The percentage of beads able to recruit the  1 integrins 
(gray bars), the GFP fusion proteins (black bars), and/or HLA (white bars) was scored using immunofluorescence. In some experiments, cells 
were preincubated with 100 nM wortmannin (D, wortmannin) for 30 min before incubation with the beads. 
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effect on cell adhesion or migration through a Transwell fil-
ter, although it did affect development of lamellipodia and
cell spreading.
We next wanted to examine if the integrin-mediated
defects we observed were due to impaired recruitment of
the Arp2/3 complex to sites of integrin clustering. Using
p34GFP, we assessed the distribution of the Arp2/3 complex
beneath FN-coated beads adhering for 15 min onto vincu-
lin-null cells reexpressing WT or mutant vinculin. We ob-
served that 59% of the beads recruited WT vinculin, and
that 33% of these beads were positive for the Arp2/3 com-
plex (Fig. 10). In contrast, cells expressing recruited vinculin
at a similar level to the beads, but only 6% of the total beads
recruited the Arp2/3 complex. Preventing binding of the
Arp2/3 complex to vinculin significantly decreased recruit-
Figure 6. Mapping the Arp2/3 complex binding site 
of vinculin. (A) Linear schematic is shown of vinculin 
and the fragments of vinculin as fusion proteins of GST 
(GST–VIN). (B and C) Association of the Arp2/3 complex 
with GST–VIN proteins. Thirty micrograms of fusion 
protein attached to beads were incubated for 1.5 h in 
the absence ( ) or presence ( ) of 10  l of a crude 
platelet fraction. The beads were sedimented, washed, 
and subjected to Western blot analysis as described. 
Note that in C, the binding of the Arp2/3 complex to 
vinculin fragments does not involve binding to actin. 
(D) Substitution of proline 878 or 876 with alanine 
prevents binding of the Arp2/3 complex to vinculin in 
vitro. 30  g of GST or GST fusions of VIN 811–881, 
VIN 811–881 with a proline to alanine mutation at 876 
(P876A) or at 878 (P878A) were examined for their 
ability to retrieve the Arp2/3 complex, ponsin, vinexin, 
or VASP from cell lysates obtained from platelets, 
MDCK, C2C12, or A431 cells, respectively. Different 
cell types were used for preparing the lysates because 
of failure to detect the antigens in some cell types. 
(E) Full-length vinculin harboring a proline to alanine 
mutation at 878 prevents recruitment of the Arp2/3 
complex, but has no effect on actin binding. Serum-
starved, Vin /  MEFs expressing an empty vector 
( / ), full-length vinculin (WT), or full-length vinculin 
with a P878A substitution (P878A) were left resting ( ) 
or stimulated ( ) with 10% FBS for 5 min, vinculin 
immunoprecipitates were obtained and analyzed.
Figure 7. Binding of the Arp2/3 complex to vinculin is direct. 
Vinculin fusion proteins attached to beads were incubated with 2 
 g of purified, human platelet Arp2/3 complex for 1.5 h at 4 C. The 
beads were washed and the pellets were examined for the ability of 
the fusion proteins to bind the Arp2/3 complex. Purified Arp2/3 
denotes a sample of Arp2/3 complex purified from platelets.
 
and formation of lamellipodia on FN, but migrated twofold
faster compared with WT cells (Xu et al., 1998b). We as-
sessed the ability of vinculin-null mouse embryo fibroblasts
(MEFs) reexpressing WT, mutant vinculin, or vector alone
to form lamellipodia in response to plating cells on fibonec-
tin for 45 min. We found that the cells reexpressing WT
vinculin were able to form robust lamellipodia. In contrast,
both the control and mutant vinculin-reexpressing cells
showed fewer, smaller lamellipodial extensions and appeared
less spread than the WT reexpressers (unpublished data). By
2 h after plating on FN, the cells reexpressing WT vinculin
were broad and flat while both the null and mutant reex-
pressing cells were more elongated and thin (Fig. 8 A). To
quantify the difference, we measured the length/width ratio
in the three cell types. This data confirmed that the null and
mutant vinculin-reexpressing cells were significantly im-
paired in their ability to spread to WT levels (Fig. 8 B).
Because vinculin has also been implicated in cell adhesion
and migration, we examined if the mutant vinculin was im-
paired in its ability to regulate these events. We assessed the
ability of the vinculin-null, WT, or mutant reexpressing cells
to adhere to FN. We observed that cells reexpressing both
the WTand mutant vinculin adhered to similar extents,
which were 1.9- and 1.7-fold more than the vinculin-null
cells, respectively (Fig. 9 A). Migration assays were per-
formed using Transwell filters in which the lower surface of
the filter was coated with FN. Migration was allowed to pro-
ceed for 6.0 h. Consistent with previous findings, we found
that the vinculin null cells migrated faster than the cells reex-
pressing WT vinculin (Xu et al., 1998b). Furthermore, the
mutant vinculin lacking an intact Arp2/3 complex binding
site was indistinguishable from WT cells. Thus, ablation of
the binding site for the Arp2/3 complex on vinculin had no 
Arp2/3 recruitment to vinculin |
 
 DeMali et al. 887
 
ment of the Arp2/3 complex to sites of integrin aggregation.
These results support the idea that binding to vinculin serves
to localize the Arp2/3 complex to sites of new 
 
 
 
1-integrin
engagement.
 
Discussion
 
Two of the important steps in the complex process of cell
migration are adhesion to the underlying substratum
and membrane protrusion. Membrane protrusion is driven
by the Arp2/3 complex nucleating actin polymerization,
whereas adhesion to ECM occurs largely through the inte-
grin family of ECM receptors. These two components of cell
migration, adhesion and protrusion, are functionally linked.
For example, it has been known for a long time that plating
cells on an ECM-coated surface stimulates membrane pro-
trusion as cells spread. Moreover, integrin-mediated adhe-
sion has been shown to activate Rac1 (Clark et al., 1998;
Price et al., 1998; Del Pozo et al., 2000, 2002). Rac1 is
known to signal to the Arp2/3 complex via the Scar/WAVE
family of proteins (Takenawa and Miki, 2001), and to stim-
ulate formation of lamellipodia and membrane ruffles (Rid-
ley et al., 1992; Nobes and Hall, 1995). Recently, evidence
for integrin-mediated release of activated Rac1 from the se-
questering protein, RhoGDI, has been provided (Del Pozo
et al., 2002). Additionally, Sturge and coworkers (Sturge et
al., 2002) have described an integrin-dependent mechanism
for activation of N-WASP, an activator of the Arp2/3 com-
plex that nucleates actin polymerization. Together these ob-
servations indicate that integrin-mediated adhesion can sig-
nal to the Arp2/3 complex, thereby promoting membrane
protrusion.
At the outset of this work, we were motivated to look for
proteins that might directly couple matrix adhesion to nu-
cleation of actin polymerization. We have found here a tran-
sient interaction of the Arp2/3 complex with vinculin that is
stimulated by matrix adhesion and by growth factor treat-
ment. The interaction of the Arp2/3 complex with vinculin
only occurs at sites of newly engaged integrins and is not de-
tected in mature adhesive structures, such as focal adhesions.
Together these observations lead us to suggest that this in-
teraction is one way that the actin nucleating machinery that
Figure 8. A vinculin mutant unable to 
associate with the Arp2/3 complex is 
impaired in lamellipodial extension and 
spreading on fibronectin. Vinculin null 
cells reexpressing vector alone (Vin / ), 
WT or mutant vinculin (P878A) were 
allowed to spread onto 50  g/ml of FN 
for 120 min (A) and then examined by 
immunofluorescence with antibodies 
against vinculin or using Alexa-conjugated 
phalloidin. The white arrows indicate 
the transfected cells. Bars, 20  m. 
(B) the extent of spreading was quanti-
fied by expressing the ratio   SD of 
the length/width of 50 cells at the 
120-min time point. The WT reexpressing 
cells are significantly more spread than 
either the null or mutant reexpressers 
(P   0.001). 
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drives membrane extension can be coupled to new sites of
cell–ECM adhesion. Further evidence supporting this idea
comes from our studies of vinculin-null cells reexpressing ei-
ther WT vinculin or a mutant form of vinculin that does not
bind Arp2/3. Whereas the WT vinculin restores normal for-
mation of lamellipodia, the mutant unable to bind Arp2/3
does not (see below).
Vinculin is a prominent component of focal adhesions
and it is notable that the Arp2/3 complex has not been de-
tected in these structures either in previous localization stud-
ies (Welch et al., 1997) or in this study using a p34GFP chi-
mera. Many vinculin-binding proteins have been identified,
and so far the Arp2/3 complex is unusual among them
in not colocalizing with vinculin in focal adhesions. The
Arp2/3 complex is prominent in the leading edge of cells,
where vinculin is also found, but much less prominently
than its localization in focal adhesions. This implies that
most of the vinculin in the cell is not associated with the
Arp2/3 complex, which is what we have found biochemi-
cally. In quiescent, stationary cells, the amount of Arp2/3
coprecipitating with vinculin is very small and often difficult
to detect. Indeed, we would probably have missed this asso-
ciation if we had not first observed it occurring in crude
platelet fractions. With hindsight, we suspect that some of
the platelets used to prepare these fractions had become acti-
vated thereby stimulating this interaction between vinculin
and the Arp2/3 complex.
The transient nature of the interaction of the Arp2/3 com-
plex with vinculin is striking. We observed that it is induced
by both adhesion to ECM and by stimulating with EGF.
Pursuing the pathways leading to this association, we deter-
mined that it was blocked by agents that inhibit PI3K or
Rac1 activity. The interaction of the Arp2/3 complex with
vinculin could be triggered by activated Rac1. In many sys-
tems, PI3K is upstream of Rac1 activation and Rac1 has been
shown to stimulate the Arp2/3 complex via the WASP/Scar
family of proteins (Aspenstrom et al., 1996; Symons et al.,
1996; Miki et al., 1998). Upon activation, the WASP/Scar
proteins undergo a conformational change exposing the
COOH-terminal VCA domain that binds and activates the
Arp2/3 complex. Thus, one way that Rac1 might promote
binding of the Arp2/3 complex to vinculin would be through
activation of the Arp2/3 complex. We tested this possibility
by adding the recombinant VCA domain to cell lysates be-
fore immunoprecipitating vinculin. We found that this sig-
nificantly increased the amount of Arp2/3 binding to vincu-
lin, confirming that the interaction required activated Arp2/3
complex. However, we also found that the binding could be
stimulated even further by addition of PIP
 
2
 
 to the lysates.
PIP
 
2
 
 binds to vinculin (Johnson and Craig, 1995b), inducing
a conformational change that dissociates the head domain
from the tail domain (Johnson and Craig, 1995b; Gilmore
and Burridge, 1996; Weekes et al., 1996; Steimle et al.,
1999). This exposes binding sites on vinculin for several of its
binding partners. Together, these results suggest that the in-
teraction of the Arp2/3 complex with vinculin requires both
activation of Arp2/3 and the open vinculin conformation.
We were curious whether the interaction of vinculin with
Arp2/3 stimulated its actin nucleating activity. However, us-
ing actin polymerization assays, we found no evidence that
vinculin is able to induce nucleation via the Arp2/3 com-
plex. Furthermore, vinculin does not bind the Arp2/3 com-
plex via an acidic domain like other Arp2/3 activators. We
conclude that the interaction serves to localize the activated
Arp2/3 complex to sites of new integrin engagement. The
transient nature of the interaction also raises the question of
how this association is turned off. One possibility is that the
Arp2/3 complex is displaced by another protein that binds
to vinculin in the same region. Several proteins (VASP, vin-
exin, and ponsin) have been identified that, like the Arp2/3
complex bind to the hinge region of vinculin (Huttelmaier
et al., 1998; Kioka et al., 1999; Mandai et al., 1999). Cur-
rently, we know little about the function of ponsin and vin-
exin and even less about how their interaction with vinculin
may be regulated. In future work, we hope to explore
whether any of these proteins displace the Arp2/3 complex
from vinculin and thus confine the interaction to the newest
sites of adhesion. Presumably, whatever mechanism dissoci-
ates the Arp2/3 complex from vinculin also prevents recruit-
ment of the Arp2/3 complex to focal adhesions.
Figure 9. Recruitment of the Arp2/3 complex to vinculin is not 
required for cell adhesion or cell migration. Vinculin-null cells 
reexpressing vector alone (Vin / ), WT vinculin, or mutant vinculin 
(P878A) were examined for the ability to adhere to 50  g/ml FN (A) 
or migrate through Transwell filters (B). The mean number of cells 
expressing vector alone that migrated through the filter was set to 
100%. The relative number of cells/field   SEM was calculated from 
the means of three independent experiments.
Figure 10. Mutation of the proline 878 ablates recruitment of the 
Arp2/3 complex to FN-coated beads. Vinculin-null cells reexpressing 
WT vinculin or vinculin with a mutated Arp2/3 complex binding 
site (P878A) were presented with beads coated with FN (50  g/ml) 
for 15 min. The percentage of beads able to recruit vinculin (light 
gray) and p34GFP (dark gray) was scored by immunofluorescence 
microscopy. 
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Vinculin-null cells have provided clues to the function of
vinculin in cells. Although the vinculin knockout mice are
embryonic lethal (Xu et al., 1998a), the fibroblasts from
these mice are surprisingly normal. Interestingly, the vincu-
lin-null cells are less adherent to ECM and show reduced
rates of spreading when plated on ECM-coated surfaces
(Coll et al., 1995; Xu et al., 1998a,b). Contrary to many
expectations, these cells can develop focal adhesions and
are able to migrate. Indeed, migration is enhanced relative
to cells expressing vinculin (Coll et al., 1995; Xu et al.,
1998a,b). Presumably, this reflects that the migration rate of
these cells is limited by the strength of their adhesions. To
explore specifically the role of the interaction of the Arp2/3
complex with vinculin, we generated a point mutation in
the binding site on vinculin for Arp2/3. This mutant vin-
culin was still able to bind to the other proteins that also
bind to the hinge region of vinculin, indicating that the
mutation was not disrupting vinculin’s conformation and
affecting multiple interactions. The mutant vinculin tar-
geted to focal adhesions and restored the adhesive proper-
ties of the cells to the same extent as the WT vinculin.
Whereas reexpression of WT vinculin restored cell spread-
ing and lamellipodia formation to normal levels, the mu-
tant vinculin did not. In these characteristics, the cells re-
sembled the null cells. As noted above, these observations
support the idea that the binding of the Arp2/3 complex to
vinculin functions to promote the extension of lamellipo-
dia and cell spreading.
We were interested in comparing the mutant and WT
vinculin-expressing cells with respect to migration. Our ini-
tial expectation was that because the mutant vinculin-
expressing cells showed diminished extension of lamellipo-
dia, that these cells would migrate more slowly than the cells
expressing WT vinculin. However, we found little difference
in the rate of migration of the two cell types and that both
migrated more slowly than the null cells. The cells reexpress-
ing WT or mutant vinculin have increased adhesion to the
substratum and we conclude that this retards their rate of
migration. This result suggests that the rate limiting step in
these cells is the release of adhesions rather than protrusion
at the leading edge.
It is clear that the vinculin-null MEFs can generate lamel-
lipodial protrusions, albeit less well than cells in which WT
vinculin has been expressed. However, there are vinculin-
deficient F9 embryonic carcinoma cells that have also been
studied. Like the MEFs devoid of vinculin, these cells also
reveal reduced adhesion and spreading on FN. In contrast to
the vinculin-null MEFs, these F9 cells lacking vinculin were
unable to develop lamellipodia (Coll et al., 1995), but con-
tinued to develop filopodia. Recent work from Goldmann
and Ingber has found that these F9 cells deficient in vincu-
lin fail to develop lamellipodia in response to Rac activation
(Goldmann and Ingber, 2002). This is restored by reexpres-
sion of WT vinculin, leading to the conclusion that vincu-
lin is critical in lamellipodial extension. However, because
MEFs lacking vinculin can generate lamellipodia, we con-
clude that multiple mechanisms are involved. For some cells
(e.g., the F9 cells) vinculin appears to be critical for this ac-
tivity, whereas for others, such as the fibroblasts used here,
the coupling of Arp2/3 to vinculin provides just one of pos-
sibly several mechanisms that contribute to lamellipodial ex-
tension.
 
Materials and methods
 
Cell lines
 
The vinculin-null mouse embryo fibroblasts (Vin
 
 
 
/
 
 
 
; Xu et al., 1998a)
were a gift of E. Adamson (Burnham Institute, La Jolla, CA). Hs68 (Ameri-
can Type Culture Collection), A431, HeLa, REF52, and Vin
 
 
 
/
 
 
 
 cell lines
were maintained in DME 
 
 
 
 10% FBS.
 
Constructs
 
The GST–vinculin fusion proteins Vin 1–399, 399–881, 881–1066 were
provided by D. Critchley (University of Leicester, Leicester, UK). All other
fusion proteins containing fragments of vinculin were constructed by PCR
amplification of the DNA of interest and subcloning the resulting DNA into
pGEX-T. To obtain GST–P876A and GST–P878A, site-specific mutagenesis
was carried out using the GST–VIN 811–881 template according to the
Quickchange Manual (Stratagene). These mutants were subcloned into
full-length vinculin in pCMV-myc (CLONTECH Laboratories, Inc.) with a
modified multiple cloning site. pGEX-VCA domain was a gift from H-Y. H.
Ho and R. Rohatgi (Harvard Medical School, Boston, MA). The GFP fusion
protein, p34GFP, was constructed by RT-PCR amplification a 
 
Sal-BamH1
 
p34-Arc subunit of the Arp2/3 complex cDNA from mRNA obtained from
HeLa cells and subcloning the resulting DNA into pEGFP-N3 (CLONTECH
Laboratories, Inc.).
 
Reagents and antibodies
 
Wortmannin (Sigma-Aldrich) and LY294002 (Alexis) were resuspended ac-
cording to the manufacturer’s specifications. Human FN was prepared (Ru-
oslahti et al., 1982) or purchased from GIBCO-BRL. PIP
 
2
 
 was a gift from
Andrew Morris (University of North Carolina, Chapel Hill, NC). The GST–
VCA protein was prepared as described (Rohatgi et al., 2000). The Arp2/3
complex for the actin polymerization studies was purified as described
(Welch and Mitchison, 1998). The Arp2/3 complex used in the binding
studies was provided by D. Yaarar (University of California, Berkeley, CA).
The Arp2/3 complex was blotted using a rabbit antibody raised against a
peptide that included amino acids 179–204 of the p34-Arc subunit of the
Arp2/3 complex. Vinculin was immunoprecipitated and blotted using a
rabbit antibody raised against purified chicken gizzard vinculin. Antibod-
ies against VASP and Rac1 were obtained from Transduction Labs, against
HLA from Pharmingen, and against integrins (TS2/16) from American Type
Culture Collection. Affinity-purified, anti-vinexin antibody was a gift from
N. Kioka (Kyoto University, Kyoto, Japan). The ponsin antibody (Mandai et
al., 1999) was a gift from Y. Takai (Osaka University School of Medicine,
Osaka, Japan).
Bead experiments were carried out as previously described with minor
modifications (Miyamoto et al., 1995). Latex beads (3.0 
 
 
 
m) were coated
with 50 
 
 
 
g/mL human plasma FN or 100 
 
 
 
g/mL of poly-lysine for 1.0 h at
37
 
 
 
C and then blocked using 10 mg/mL BSA. HeLa or Vin
 
 
 
/
 
 
 
 cells tran-
siently expressing p34GFP or GFP were plated on collagen-coated cover-
slips for 1.0 h at 37
 
 
 
C, washed in PBS, and 1.0 
 
  
 
10
 
6
 
 beads were incu-
bated with the coverslips for the times indicated. The coverslips were
fixed, permeabilized, and stained with antibodies against vinculin, 
 
 
 
1-
integrins or HLA, followed by a Texas red–conjugated secondary antibody.
For each experiment, 
 
 
 
150 beads were scored for the presence or absence
of fluorescence around the beads. Values are number of positive beads 
 
 
 
SEM from at least three independent experiments.
 
Rac1 activity
 
To measure Rac1 activity, A431 cells were left resting or stimulated with
EGF at specified time points, cells were washed, lysed, and active GTP-
bound Rac1 was precipitated using GST-PBD beads, as described (Ba-
grodia et al., 1998). Densitometric analysis of films was performed as de-
scribed (Liu and Burridge, 2000).
 
Immunoprecipitation and Western blot analysis
 
For the EGF stimulation experiments, subconfluent A431 cells were
starved for 24 h in DME 
 
 
 
 0.1% FBS and then stimulated with human EGF
in 2 mM acetic acid, 10 mg/mL BSA at a concentration of 100 ng/mL. Con-
trol cells were treated with an equivalent amount of 2 mM acetic acid, 10
mg/mL BSA. For the cell spreading on FN experiments, cells were
trypsinized, washed three times in DME, and plated onto FN-coated cover-
slips submerged in a 6-well plate at a density of 1.33 
 
 
 
 10
5 cells. The890 The Journal of Cell Biology | Volume 159, Number 5, 2002
plates were centrifuged at 300 g for 5 min and allowed to spread for the
times indicated at 37 C. Subsequent to stimulation of cells by EGF or
spreading on FN, the cells were washed in HBS (20 mM HEPES, pH 7.4,
150 mM NaCl   2 mM Na3VO4) and lysed in ice-cold EB (1% Triton
X-100, 10 mM Tris-HCl, pH 7.4, 5 mM EDTA, 50 mM NaCl, 50 mM NaF,
0.1% BSA, 20  g/mL aprotinin, 1 mM PMSF, 2 mM Na3VO4). For the ex-
periments addressing whether PIP2 and/or GST–VCA can induce binding of
the Arp2/3 complex to vinculin, the Triton X-100 cleared lysates were in-
cubated with 10 mM PIP2 and/ or 30  g GST–VCA. Vinculin was immuno-
precipitated with a polyclonal antibody raised against chicken gizzard vin-
culin, the immunoprecipitates were washed four times in ice-cold EB,
fractionated by SDS-PAGE, transferred to PVDF membranes, and subjected
to Western blot analysis. 20% of the immunoprecipitate was analyzed for
vinculin recovered, 10% was used for the actin blots, and between 70 and
80% was analyzed for p34-Arc coprecipitation. The blots were developed
with Western blot detection reagents (ECL; Amersham Biosciences), and
the signal was detected on x-ray film.
Migration assays
Migration assays were performed using Transwell cell culture chambers
containing polycarbonate membrane inserts with 8.0  m pores (Becton-
Dickinson) as previously described (Xu et al., 1998a). The filters were pro-
cessed for immunofluorescence as described above and stained with DAPI
(Sigma-Aldrich) to stain nuclei.
Adhesion assays
Cells were plated on coverslips coated with 50  g/mL of human FN, al-
lowed to adhere for 45 min at 37  C, rinsed three times with PBS, and then
processed for immunofluorescence and stained with DAPI (Sigma-Aldrich).
Immunofluorescence
Cells were fixed, permeabilized, and washed as described (Liu and Bur-
ridge, 2000). Cells were incubated with primary antibodies for 1.0 h at
room temperature, washed, and incubated with secondary antibody for
1.0 h at room temperature. Vinculin and myc monoclonal antibodies
(Sigma-Aldrich) were used at 1:50 and 1:1,000, respectively. Alexa fluoro
594-conjugated phalloidin (Molecular Probes) was used to visualize actin
at 1:200. Images were obtained as described (Liu and Burridge, 2000).
Spreading assays
Cells were seeded onto coverslips coated with 50  g/mL of human FN and
incubated for 45 or 120 min at 37 C. The cells were then processed for im-
munofluorescence.
Microinjection
Cells were cultured and microinjected as previously described (Nobes and
Hall, 1995).
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